FIELD: chemistry.
SUBSTANCE: invention relates to a novel compound N-(1-{(3R)-3-(3,5-difluorophenyl)-3-[1-(methylsulfonyl) piperidin-4-yl]propyl}piperidin-4-yl)-N-ethyl-2-[4- (methylsufonyl)phenyl]acetamide or its pharmaceutically acceptable salts. The invention also relates to a method for synthesis of the compound in paragraph 1, as well as to a pharmaceutical composition.
EFFECT: obtaining a novel biologically active compound with activity towards CCR5 (chemokine receptor 5).
6 cl, 6 ex, 2 tbl
Authors
Dates
2010-02-10—Published
2005-06-20—Filed